Ho Lee

Professor

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Cancer Biology Cancer Biology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Ho Lee is a faculty member at the National Cancer Center in South Korea. His research focuses on various aspects of cancer biology, including the roles of monoclonal antibodies in treating triple-negative breast cancer, the impact of glucose deprivation on cancer cell mortality, and advancements in genome editing tools for disease modeling. He has published several articles on topics such as obesity-associated cancers and post-translational modifications in cancer progression.

Articles (12)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Jong In Yook

Professor

Yonsei University College of Dentistry

SOUTH KOREA

View details

Je Kyung Seong

Assistant Professor, Associate Professor, Professor

Seoul National University

SOUTH KOREA

View details

Chang Hoon Lee

SOUTH KOREA

View details

Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Soo-Youl Kim

Head

National Cancer Center

SOUTH KOREA

View details

Kyoungmi Kim

Associate Professor

Korea University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ho Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Anti-PTK7 Monoclonal Antibodies Suppresses Oncogenic Phenotypes in Cellular and Xenograft Models of Triple-Negative Breast Cancer

Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications

Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation

Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent

Novel Variant in <i>CEP250</i> Causes Protein Mislocalization and Leads to Nonsyndromic Autosomal Recessive Type of Progressive Hearing Loss

PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells

Post-Translational Modification of ZEB Family Members in Cancer Progression

Obesity-Associated Cancers: Evidence from Studies in Mouse Models

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer

Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells.

Resolvin D1 Suppresses H<sub>2</sub>O<sub>2</sub>-Induced Senescence in Fibroblasts by Inducing Autophagy through the miR-1299/ARG2/ARL1 Axis

LW1497, an Inhibitor of Malate Dehydrogenase, Suppresses TGF-β1-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells by Downregulating Slug

Collaborators (12)

Jong In Yook

Je Kyung Seong

Chang Hoon Lee

Heon Yung Gee

Chang-Woo Lee

Tae Jin Kim

Hyonchol Jang

Hyun Sil Kim

Seung-Taek Lee

Eun-Ji Park

Soo-Youl Kim

Kyoungmi Kim

Make your next move.